Discover 1,461 paid clinical trials in Renton, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,461
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
for
Solid Tumors
Location: Puyallup WA, Portland OR, Spokane WA, Los Angeles CA,
Sponsor: DualityBio Inc.
Sex: All
Age: 18+
Code: NCT06953089
Phase 2, Recruiting
FAmily Engagement Strategy for Coordinated Specialty Care
for
Family Members, Implementation
Location: Tacoma WA, Yakima WA, Pasco WA
Sponsor: Washington State University
Sex: All
Age: 18+
Code: NCT06945055
Recruiting
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
for
Non-Small-Cell Lung Cancer,
Location: Edmonds WA, Vancouver, Calgary, Edmonton, Sacramento CA,
Sponsor: ArriVent BioPharma, Inc.
Sex: All
Age: 18+
Code: NCT07185997
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
for
Major Depressive Disorder (MDD),
Location: Everett WA, Glendale CA, San Jose CA, Redlands CA,
Sponsor: Seaport Therapeutics
Sex: All
Age: 18 - 65
Code: NCT07065240
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Adapting a Brief Suicide Intervention for Pediatric Primary Care: Enhancing Uptake and Impact
for
Suicide Prevention
Location: Mountlake Terrace WA, Olympia WA, Centralia WA
Sponsor: University of Washington
Sex: All
Age: 10+
Code: NCT06499740
Recruiting
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
for
Ulcerative Colitis, Obesity or Overweight
Location: Tacoma WA, Vancouver, Idaho Falls ID, Northridge CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70
Code: NCT06937086
Phase 3, Recruiting
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease